Alkermes (ALKS) Enterprise Value (2010 - 2026)
Alkermes' (ALKS) quarterly Enterprise Value came in at -$511.9 million in Q1 2026, up 42.1% year-on-year from -$360.2 million in Q1 2025, and up 54.29% on a QoQ basis from -$1.1 billion in Q4 2025.
Alkermes (ALKS) Enterprise Value (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Enterprise Value data on file, last reported at -$511.9 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 42.1% year-over-year to -$511.9 million in Q1 2026; TTM through Mar 2026 was -$511.9 million, a 42.1% increase from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 48.97% from the prior year.
- Enterprise Value for Q1 2026 stood at -$511.9 million, up from -$1.1 billion in the prior quarter.
- Over the last five years, Enterprise Value for ALKS reached as high as -$511.9 million in Q1 2026 and fell as low as -$1.1 billion in Q4 2025.
- Historically, Enterprise Value has averaged -$783.2 million across 5 years, with a median of -$773.5 million in 2023.
- Across the five-year window, Enterprise Value tumbled 53.25% in 2023 and soared 42.1% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$608.5 million in 2022, then decreased by 27.12% to -$773.5 million in 2023, then grew by 2.82% to -$751.7 million in 2024, then plunged by 48.97% to -$1.1 billion in 2025, then surged by 54.29% to -$511.9 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$511.9 million in Q1 2026, -$1.1 billion in Q4 2025, and -$1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -511.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -511.86 Mn |
| Dec 31, 2025 | -1.12 Bn |
| Sep 30, 2025 | -1.11 Bn |
| Jun 30, 2025 | -1.02 Bn |
| Mar 31, 2025 | -884.02 Mn |
| Dec 31, 2024 | -751.67 Mn |
| Sep 30, 2024 | -908.86 Mn |
| Jun 30, 2024 | -876.12 Mn |
| Mar 31, 2024 | -745.05 Mn |
| Dec 31, 2023 | -773.49 Mn |
| Sep 30, 2023 | -889.15 Mn |
| Jun 30, 2023 | -829.05 Mn |
| Mar 31, 2023 | -600.46 Mn |
| Dec 31, 2022 | -608.47 Mn |
| Sep 30, 2022 | -580.18 Mn |
| Jun 30, 2022 | -580.97 Mn |
| Mar 31, 2022 | -528.87 Mn |
| Dec 31, 2021 | -536.31 Mn |
| Sep 30, 2021 | -560.30 Mn |
| Jun 30, 2021 | -538.35 Mn |